Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Xenotransplantation

E Cozzi1, D J White

  • 1Department of Surgery, University of Cambridge, UK.

Current Opinion in Nephrology and Hypertension
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Pig organ xenotransplantation offers a solution for organ shortages but faces hyperacute rejection. Genetic engineering now produces organs resistant to rejection, overcoming a major barrier in transplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of the Branching Fraction Ratios R(D^{+}) and R(D^{*+}) Using Muonic τ Decays.

Physical review letters·2025
Same author

Observation of Exotic J/ψϕ Resonant Structure in Diffractive Processes in Proton-Proton Collisions.

Physical review letters·2025
Same author

Observation of New Charmonium or Charmoniumlike States in B^{+}→D^{*±}D^{∓}K^{+} Decays.

Physical review letters·2024
Same author

Search for Time-Dependent CP Violation in D^{0}→π^{+}π^{-}π^{0} Decays.

Physical review letters·2024
Same author

Modification of χ_{c1}(3872) and ψ(2S) Production in pPb Collisions at sqrt[s_{NN}]=8.16  TeV.

Physical review letters·2024
Same author

Amplitude Analysis of the B^{0}→K^{*0}μ^{+}μ^{-} Decay.

Physical review letters·2024
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
Same journal

Social determinants of chronic kidney disease: from association to clinical and population action.

Current opinion in nephrology and hypertension·2026
Same journal

Advancing science and care in CKD-MBD: the layered path to legacy.

Current opinion in nephrology and hypertension·2026
See all related articles

Area of Science:

  • Transplantation immunology
  • Xenotransplantation research
  • Genetic engineering in medicine

Background:

  • The global organ shortage necessitates alternative solutions like xenotransplantation.
  • Hyperacute rejection (HAR) of xenografts is a primary obstacle to successful pig-to-human transplantation.
  • Recent advancements have clarified the immunological mechanisms underlying HAR.

Purpose of the Study:

  • To review recent progress in understanding hyperacute rejection.
  • To describe novel biomolecular strategies for overcoming xenograft rejection.
  • To highlight the potential of genetically modified pig organs for human transplantation.

Main Methods:

  • Review of current literature on xenotransplantation and rejection mechanisms.

Related Experiment Videos

  • Analysis of immunological factors contributing to hyperacute rejection.
  • Examination of genetic engineering techniques applied to donor animals.
  • Main Results:

    • Understanding of hyperacute rejection immunological pathways has significantly advanced.
    • Genetically engineered pig organs demonstrate reduced susceptibility to hyperacute rejection.
    • Biomolecular approaches are effectively mitigating key rejection factors.

    Conclusions:

    • Genetically modified pig organs represent a promising strategy to overcome xenograft rejection.
    • Advances in understanding rejection mechanisms pave the way for clinical xenotransplantation.
    • Xenotransplantation holds potential to alleviate the critical shortage of human organs.